The Precision Peptide Genetic Test identifies your genetic predispositions in GLP-1 and GIP pathways, helping providers personalize your therapy for safer, more effective outcomes
Analysts at Goldman Sachs predict that by 2030, 15 million Americans will be on these drugs, butwith limited insurance coverage and monthly out-of-pocket prices of about $900 to $1300the question is, how will they afford it
high production of uric acid by the body
Downstream, researchers report stronger learning signals, better memory on rodent tasks, and sharper thinking under stress, along with signals of neuroprotection in stroke-injury models
2016;11(1): e0147788
Compounded formulations with B12 address the vitamin B12 depletion that can occur with long-term GLP-1 therapy